AI assistant
Arcadia Biosciences, Inc. — Director's Dealing 2015
May 15, 2015
35424_dirs_2015-05-14_9ce928bc-9ac8-4d34-b787-e7889a3efe56.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2015-05-14
Reporting Person: Salameh Roger (VP Business Development)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 0 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $0.44 | 2015-12-31 | Common Stock (27500) | Direct | |
| Employee Stock Option (right to buy) | $1.08 | 2018-06-30 | Common Stock (72500) | Direct | |
| Employee Stock Option (right to buy) | $2.24 | 2019-10-31 | Common Stock (25000) | Direct | |
| Employee Stock Option (right to buy) | $2.24 | 2019-12-31 | Common Stock (50000) | Direct | |
| Employee Stock Option (right to buy) | $13.56 | 2020-12-31 | Common Stock (12500) | Direct | |
| Employee Stock Option (right to buy) | $13.56 | 2022-12-31 | Common Stock (18750) | Direct | |
| Employee Stock Option (right to buy) | $6.12 | 2024-10-29 | Common Stock (12500) | Direct |
Footnotes
F1: The option is fully exercisable as of the date hereof.
F2: The option vested as to 25% of the shares on the date of grant, with the remaining 75% of shares vesting in equal quarterly installments beginning on March 31, 2013 and ending on December 31, 2015. All unvested shares shall become fully exercisable upon the closing of the issuer's initial public offering.
F3: The option vested as to 50% of the shares on February 7, 2015, with the remaining 50% of shares vesting in equal monthly installments beginning on February 28, 2015 and ending on January 31, 2017.